Glenmark Pharmaceuticals Limited (BOM:532296)
1,660.15
+6.40 (0.39%)
At close: Jun 18, 2025
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 462.58 billion as of June 20, 2025. Its market cap has increased by 41.27% in one year.
Market Cap
462.58B
Enterprise Value
470.25B
Revenue
134.35B
Ranking
n/a
PE Ratio
44.18
Stock Price
1,660.15
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 462.58B, an increase of 40,149.04%. That is a compound annual growth rate of 28.32%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.17T |
HDFC Bank | 14.83T |
Tata Consultancy Services | 12.49T |
Bharti Airtel | 11.17T |
ICICI Bank | 10.08T |
State Bank of India | 7,067.41B |
Infosys | 6,767.74B |
Life Insurance Corporation of India | 5,911.34B |